Ir directamente a la navegación principal
Ir directamente a la búsqueda
Ir directamente al contenido principal
Clasificar por
Keyphrases
Apoptosis
16%
C-C Chemokine Receptor Type 5 (CCR5)
83%
CCL5
100%
CCR5 Antagonist
33%
CCR5-CCL5 Axis
33%
Cell Proliferation
16%
Cervical Lymph Node
16%
Cytoskeletal Organization
16%
Dose-dependent
16%
In Vivo Evidence
16%
Malignant Cells
16%
Maraviroc
100%
Metastasis
100%
Microenvironment
16%
Neck Metastasis
16%
New Therapies
16%
Oncological Treatment
16%
Oral Cancer
33%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
100%
Orthotopic Xenograft Model
16%
Overall Survival
16%
Paraffin-embedded Tissue
16%
Poor Outcome
100%
Primary Tumor
16%
Related Pathway
16%
Short Hairpin RNA (shRNA)
33%
Therapeutic Potential
16%
Tongue Cancer
16%
Tumor Progression
16%
Medicine and Dentistry
Cell Line
16%
Cell Proliferation
16%
Cervical Lymph Node
16%
Chemokine Receptor CCR5 Antagonist
33%
Clinical Stage
16%
In Vitro
16%
Maraviroc
100%
Mouth Squamous Cell Carcinoma
100%
Neck Metastasis
16%
Oral Cancer
33%
Overall Survival
16%
Primary Tumor
16%
Programmed Cell Death
16%
Receptor
16%
Retrospective Study
16%
Short Hairpin RNA
33%
Tongue Cancer
16%
Tumor Progression
16%
Xenograft
16%
Pharmacology, Toxicology and Pharmaceutical Science
Chemokine Receptor CCR5 Antagonist
33%
Maraviroc
100%
Mouth Cancer
33%
Mouth Squamous Cell Carcinoma
100%
Neck Metastasis
16%
Overall Survival
16%
Primary Tumor
16%
Receptor
16%
Retrospective Study
16%
Short Hairpin RNA
33%
Tongue Cancer
16%
Tumor Growth
16%
Biochemistry, Genetics and Molecular Biology
CCL5
100%
CCR5
100%
Cell Proliferation
11%
Overall Survival
11%
Programmed Cell Death
11%
Retrospective Study
11%
Small Hairpin RNA
22%
Small Interfering RNA
22%
Tumor Progression
11%